Midgard Science

Labs / CDMO: development & manufacturing

Isomab

Nottingham, United Kingdom · isomab.bio

GMP

On your own

Free. Their own email.

Contact Isomab directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Isomab is a UK-based biopharmaceutical company developing first-in-class antibody therapies for cardiovascular diseases. It is working on ISM-001, an antibody therapeutic for chronic angina that aims to restore collateral vessel growth in the heart, and was spun out of the University of Nottingham in 2022.

They take quote requests by email.

What they offer

  • Antibody therapy development

    Develops first-in-class antibody therapies for cardiovascular diseases.

  • Cardiovascular drug development

    Advances disease-modifying therapeutics for coronary heart disease and chronic angina.

  • Translational development

    Translates VEGF biology into therapies aimed at restoring healthy blood flow in the heart.

What they work on

Modalities
Small molecule, Antibody
Therapeutic areas
cardiovascular disease, coronary heart disease, chronic angina
Sites
Nottingham, United Kingdom
Serves
UK, Europe, United States
Founded
2006

Similar labs. Adragos Pharma, ANGITIA, ARSI Canada Inc, Esco Aster

Found in a contract services directory. Listing built from isomab.bio. Work here? Claim this listing.

Isomab · Midgard Science